Applying Lipidomics to Non-Alcoholic Fatty Liver Disease: A Clinical Perspective
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Applying Lipidomics to Non-Alcoholic Fatty Liver Disease: A Clinical Perspective
Authors
Keywords
-
Journal
Nutrients
Volume 15, Issue 8, Pages 1992
Publisher
MDPI AG
Online
2023-04-21
DOI
10.3390/nu15081992
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Concise review of lipidomics in nonalcoholic fatty liver disease
- (2023) Sarah Béland-Bonenfant et al. DIABETES & METABOLISM
- Metabolic Profile Reflects Stages of Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease
- (2023) Nila Jambulingam et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cancer statistics, 2022
- (2022) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The altered lipidome of hepatocellular carcinoma
- (2022) Shawn Lu Wen Tan et al. SEMINARS IN CANCER BIOLOGY
- Lipotoxicity as the Leading Cause of Non-Alcoholic Steatohepatitis
- (2022) Marija Branković et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Role of hepatic lipid species in the progression of nonalcoholic fatty liver disease
- (2022) Ke-Qiong Deng et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Discriminatory changes in circulating metabolites as a predictor of hepatocellular cancer in patients with MAFLD
- (2022) Haonan Lu et al. Liver Cancer
- The role of lipids in cancer progression and metastasis
- (2022) Miguel Martin-Perez et al. Cell Metabolism
- Advances in mass spectrometry imaging for spatial cancer metabolomics
- (2022) Xin Ma et al. MASS SPECTROMETRY REVIEWS
- SPARC inhibition accelerates NAFLD‐associated hepatocellular carcinoma development by dysregulating hepatic lipid metabolism
- (2021) Agostina Onorato et al. LIVER INTERNATIONAL
- Metabolic Spectrum of Liver Failure in Type 2 Diabetes and Obesity: From NAFLD to NASH to HCC
- (2021) Hyunmi Kim et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Hepatic lipidomic remodeling in severe obesity manifests with steatosis and does not evolve with non-alcoholic steatohepatitis
- (2021) Geraldine J. Ooi et al. JOURNAL OF HEPATOLOGY
- Ethnicity-specific alterations of plasma and hepatic lipidomic profiles are related to high NAFLD rate and severity in Hispanic Americans, a pilot study
- (2021) Tagreed A. Mazi et al. FREE RADICAL BIOLOGY AND MEDICINE
- LC-MS-based lipidomic analysis in distinguishing patients with nonalcoholic steatohepatitis from nonalcoholic fatty liver
- (2021) Zhong-Hua Wang et al. Hepatobiliary & Pancreatic Diseases International
- Identification of a glycolysis‐related gene signature for survival prediction of ovarian cancer patients
- (2021) Dai Zhang et al. Cancer Medicine
- The altered serum lipidome and its diagnostic potential for Non-Alcoholic Fatty Liver (NAFL)-associated hepatocellular carcinoma
- (2021) Monika Lewinska et al. EBioMedicine
- CPT1A-mediated Fat Oxidation, Mechanisms, and Therapeutic Potential
- (2020) Isabel R Schlaepfer et al. ENDOCRINOLOGY
- Lipid remodelling in hepatocyte proliferation and hepatocellular carcinoma
- (2020) Zoe Hall et al. HEPATOLOGY
- Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives
- (2020) Natascha Roehlen et al. Cells
- Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites
- (2020) Xiang Zhang et al. GUT
- NASH, Fibrosis and Hepatocellular Carcinoma: Lipid Synthesis and Glutamine/Acetate Signaling
- (2020) Yoshiaki Sunami INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver?
- (2020) Patricia Rada et al. Cell Death & Disease
- Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention
- (2020) Daniel Q. Huang et al. Nature Reviews Gastroenterology & Hepatology
- Diagnosis of non-alcoholic fatty liver disease (NAFLD): current concepts.
- (2019) Margarita Papatheodoridi et al. CURRENT PHARMACEUTICAL DESIGN
- A New Targeted Lipidomics Approach Reveals Lipid Droplets in Liver, Muscle and Heart as a Repository for Diacylglycerol and Ceramide Species in Non-Alcoholic Fatty Liver
- (2019) Christina Preuss et al. Cells
- Derivation and validation of a cardiovascular risk score for prediction of major acute cardiovascular events in non-alcoholic fatty liver disease; the importance of an elevated mean platelet volume
- (2019) Robin D. Abeles et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Lipidomic biomarkers and mechanisms of lipotoxicity in non-alcoholic fatty liver disease
- (2019) Gianluca Svegliati-Baroni et al. FREE RADICAL BIOLOGY AND MEDICINE
- SIRT3 promotes lipophagy and chaperon-mediated autophagy to protect hepatocytes against lipotoxicity
- (2019) Tian Zhang et al. CELL DEATH AND DIFFERENTIATION
- Industrial Trans Fatty Acids Stimulate SREBP2‐mediated Cholesterogenesis and Promote non‐alcoholic Fatty Liver Disease
- (2019) Antwi‐Boasiako Oteng et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Biomarkers and subtypes of deranged lipid metabolism in non-alcoholic fatty liver disease
- (2019) José M Mato et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Sphingolipids in Non-Alcoholic Fatty Liver Disease and Hepatocellular Carcinoma: Ceramide Turnover
- (2019) Jorge Simon et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Non-invasive diagnosis of non-alcoholic steatohepatitis and fibrosis with the use of omics and supervised learning: A proof of concept study
- (2019) Nikolaos Perakakis et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Spatial Systems Lipidomics Reveals Nonalcoholic Fatty Liver Disease Heterogeneity
- (2018) Klára Ščupáková et al. ANALYTICAL CHEMISTRY
- Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease
- (2018) David Højland Ipsen et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Defective lysosomal clearance of autophagosomes and its clinical implications in nonalcoholic steatohepatitis
- (2018) Xiaojuan Wang et al. FASEB JOURNAL
- Association between non-alcoholic fatty liver disease and cancer incidence rate
- (2018) Gi-Ae Kim et al. JOURNAL OF HEPATOLOGY
- Lipotoxicity and the gut-liver axis in NASH pathogenesis
- (2018) Fabio Marra et al. JOURNAL OF HEPATOLOGY
- Changes in lysophospholipids and liver status after weight loss: the RESMENA study
- (2018) Irene Cantero et al. Nutrition & Metabolism
- Mitochondrial dysfunction-related lipid changes occur in non-alcoholic fatty liver disease progression
- (2018) Kang-Yu Peng et al. JOURNAL OF LIPID RESEARCH
- Histone H3K9 demethylase JMJD2B induces hepatic steatosis through upregulation of PPARγ2
- (2018) Ji-Hyun Kim et al. Scientific Reports
- Characterization of different fat depots in NAFLD using inflammation-associated proteome, lipidome and metabolome
- (2018) Alen Lovric et al. Scientific Reports
- ANNALS EXPRESS: Bile acids and the metabolic syndrome
- (2018) Emma Rose McGlone et al. ANNALS OF CLINICAL BIOCHEMISTRY
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
- (2017) Naga Chalasani et al. HEPATOLOGY
- Aberrant Lipid Metabolism in Hepatocellular Carcinoma Revealed by Liver Lipidomics
- (2017) Zhao Li et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Hepatocellular carcinoma in South America: Evaluation of risk factors, demographics and therapy
- (2017) Jose D. Debes et al. LIVER INTERNATIONAL
- SREBP-regulated lipid metabolism: convergent physiology — divergent pathophysiology
- (2017) Hitoshi Shimano et al. Nature Reviews Endocrinology
- Pharmacological inhibition of adipose triglyceride lipase corrects high-fat diet-induced insulin resistance and hepatosteatosis in mice
- (2017) Martina Schweiger et al. Nature Communications
- Comparison of hepatic and serum lipid signatures in hepatocellular carcinoma patients leads to the discovery of diagnostic and prognostic biomarkers
- (2017) Yonghai Lu et al. Oncotarget
- Metabolism dysregulation induces a specific lipid signature of nonalcoholic steatohepatitis in patients
- (2017) Franck Chiappini et al. Scientific Reports
- Omega-3 PUFA modulate lipogenesis, ER stress, and mitochondrial dysfunction markers in NASH – Proteomic and lipidomic insight
- (2017) Lívia Samara dos Reis Rodrigues Okada et al. CLINICAL NUTRITION
- Lipotoxicity in steatohepatitis occurs despite an increase in tricarboxylic acid cycle activity
- (2016) Rainey E. Patterson et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Ceramide and polyunsaturated phospholipids are strongly reduced in human hepatocellular carcinoma
- (2016) Sabrina Krautbauer et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Lipid-Induced Signaling Causes Release of Inflammatory Extracellular Vesicles From Hepatocytes
- (2016) Petra Hirsova et al. GASTROENTEROLOGY
- Biopsy and Noninvasive Methods to Assess Progression of Nonalcoholic Fatty Liver Disease
- (2016) Pierre Bedossa et al. GASTROENTEROLOGY
- Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease
- (2016) Panu K. Luukkonen et al. JOURNAL OF HEPATOLOGY
- The Warburg Effect: How Does it Benefit Cancer Cells?
- (2016) Maria V. Liberti et al. TRENDS IN BIOCHEMICAL SCIENCES
- Inhibition of hedgehog signaling ameliorates hepatic inflammation in mice with nonalcoholic fatty liver disease
- (2015) Hyunjoo Kwon et al. HEPATOLOGY
- Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009
- (2015) Zobair M. Younossi et al. HEPATOLOGY
- Ultra-high-performance liquid chromatography electrospray ionization tandem mass spectrometry for accurate analysis of glycerophospholipids and sphingolipids in drug resistance tumor cells
- (2015) Lin Li et al. JOURNAL OF CHROMATOGRAPHY A
- Biomarkers of NAFLD progression: a lipidomics approach to an epidemic
- (2015) D. Lee Gorden et al. JOURNAL OF LIPID RESEARCH
- Targeting SREBP-1-driven Lipid Metabolism to Treat Cancer
- (2015) Deliang Guo et al. CURRENT PHARMACEUTICAL DESIGN
- Polyunsaturated fatty acid metabolites as novel lipidomic biomarkers for noninvasive diagnosis of nonalcoholic steatohepatitis
- (2014) Rohit Loomba et al. JOURNAL OF LIPID RESEARCH
- The Warburg effect then and now: From cancer to inflammatory diseases
- (2013) Eva M. Palsson-McDermott et al. BIOESSAYS
- Integrated Metabolite and Gene Expression Profiles Identify Lipid Biomarkers Associated With Progression of Hepatocellular Carcinoma and Patient Outcomes
- (2013) Anuradha Budhu et al. GASTROENTEROLOGY
- Palmitate-induced Activation of Mitochondrial Metabolism Promotes Oxidative Stress and Apoptosis in H4IIEC3 Rat Hepatocytes
- (2013) Robert A. Egnatchik et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Mechanisms for Insulin Resistance: Common Threads and Missing Links
- (2012) Varman T. Samuel et al. CELL
- Epigenetic modification of liver mitochondrial DNA is associated with histological severity of nonalcoholic fatty liver disease
- (2012) Carlos Jose Pirola et al. GUT
- Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis
- (2012) Giovanni Musso et al. PROGRESS IN LIPID RESEARCH
- Increased Diacylglycerols Characterize Hepatic Lipid Changes in Progression of Human Nonalcoholic Fatty Liver Disease; Comparison to a Murine Model
- (2011) D. Lee Gorden et al. PLoS One
- Human Fatty Liver Disease: Old Questions and New Insights
- (2011) J. C. Cohen et al. SCIENCE
- An LXR Agonist Promotes Glioblastoma Cell Death through Inhibition of an EGFR/AKT/SREBP-1/LDLR-Dependent Pathway
- (2011) D. Guo et al. Cancer Discovery
- The biliary HCO3− umbrella: A unifying hypothesis on pathogenetic and therapeutic aspects of fibrosing cholangiopathies
- (2010) Ulrich Beuers et al. HEPATOLOGY
- Peroxisome proliferator activated receptor α (PPARα) and PPAR gamma coactivator (PGC-1α) induce carnitine palmitoyltransferase IA (CPT-1A) via independent gene elements
- (2010) Shulan Song et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Structural insight into function and regulation of carnitine palmitoyltransferase
- (2009) Arne C. Rufer et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- EGFR Signaling Through an Akt-SREBP-1-Dependent, Rapamycin-Resistant Pathway Sensitizes Glioblastomas to Antilipogenic Therapy
- (2009) D. Guo et al. Science Signaling
- Chemosensitivity Determinants of Irinotecan Hydrochloride in Hepatocellular Carcinoma Cell Lines
- (2008) Takenori Takahata et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Docosahexaenoic acid (DHA) and hepatic gene transcription
- (2008) Donald B. Jump et al. CHEMISTRY AND PHYSICS OF LIPIDS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search